Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
March 11, 2025 09:00 ET
|
Resmed, Inc.
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a...
ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
February 26, 2025 03:00 ET
|
ResMed Inc.
7 out of 10 employed respondents have called in sick at least once in their career due to poor sleep.18% of couples reported sleeping in separate rooms due to snoring and restlessness.Women report...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
January 30, 2025 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 10%, operating profit up 52%, non-GAAP operating profit up 19%Operating cash flow of $309 million Note: A webcast of ResMed’s conference call will be available at 4:30...
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
January 09, 2025 16:05 ET
|
ResMed Inc.
SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on...
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 16:05 ET
|
ResMed Inc.
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will...
ResMed Announces Participation in the UBS Global Healthcare Conference
November 05, 2024 16:05 ET
|
ResMed Inc.
SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will...
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
October 24, 2024 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 11%, operating profit up 34%, non-GAAP operating profit up 27%Operating cash flow of $326 million Note: A webcast of ResMed’s conference call will be available at 4:30...
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
October 03, 2024 16:05 ET
|
ResMed Inc.
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday,...
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
September 30, 2024 16:05 ET
|
ResMed Inc.
2030 ambition to help more than 500 million people worldwide achieve their full health potentialShowcases integration of intelligent products and solutions within the ResMed ecosystem, designed to...
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
September 30, 2024 09:48 ET
|
ResMed Inc.
ResMed Unveils New Collection of Digital and Personalized Solutions designed to
Improve Sleep Health